Tag: Scottsdale Healthcare
Clinical Trial for GI Carcinoid Patients Recruiting Through September
Gastrointestinal carcinoid patients who have tumors that either are not suitable for standard treatment or are not responding to standard treatment have the opportunity to enroll in a Phase I/II clinical trial conducted by Tekmira Pharmaceuticals…
READ MORECarcinoid Cancer Foundation Presents Symposium on Cutting-Edge Treatment
Determining Molecular Signature: A Guide for Targeted Therapy of Neuroendocrine Tumors
Imagine a treatment created just for you as a carcinoid or other neuroendocrine tumor patient based upon a personalized genomic analysis. This is the cutting-edge…
READ MORESteve Jobs, Pancreatic Neuroendocrine Tumor Patient, Talks about Liver Transplant
Steve Jobs, CEO of Apple, is the most well-known member of the carcinoid and neuroendocrine tumor community. He was diagnosed with an islet cell pancreatic neuroendocrine tumor (NET) in 2004 for which he had surgery, followed by a liver transplant in …
READ MORE